Authors: Chillon, MC Garcia-Sanz, R Balanzategui, A Ramos, F Fernandez-Calvo, J Rodriguez, MJ Rodriguez-Salazar, MI Corrales, A Calmuntia, MJ Orfao, A Gonzalez, M San Miguel, JF

Citation: Mc. Chillon et al., Molecular characterization of acute myeloblastic leukemia according to thenew WHO classification: a different distribution in Central-West Spain, HAEMATOLOG, 86(2), 2001, pp. 162-166

Authors: San Miguel, JF Vidriales, MB Lopez-Berges, C Diaz-Mediavilla, J Gutierrez, N Canizo, C Ramos, F Calmuntia, MJ Perez, JJ Gonzalez, M Orfao, A

Citation: Jf. San Miguel et al., Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contributeto postinduction treatment stratification, BLOOD, 98(6), 2001, pp. 1746-1751

Authors: Martinez, A San Miguel, JF Vidriales, MB Ciudad, J Caballero, MD Lopez-Berges, MC Moro, MJ Calmuntia, MJ Ortega, F Orfao, A

Citation: A. Martinez et al., An abnormal CD34(+) myeloid/CD34(+) lymphoid ratio at the end of chemotherapy predicts relapse in patients with acute myeloid leukemia, CYTOMETRY, 38(2), 1999, pp. 70-75